Introducing: CBD Medical Journal

Introducing: the CBD Medical Journal

An exciting new medical journal just came online this month. The CBD Medical Journal is dedicated to Medical Marijuana and CBD Health and Wellness.

See below for just a few of the exclusive articles you will only find at our CBD companion site, the CBD Medical Journal:

Check it out today, and be sure to tell your friends!

Five Top Marijuana Strains@0.5x News-Vermont-to-be-9th-legalize-marijuana-v2
Marijuana for Pets Marijuana Alcohol Sex Feature Image
Five Low-THC Marijuana Strains News- WSU Pot Study May 2017

 

 

Vermont Set To Expand Medical Marijuana

Copyright © Erik Muenker 2017 All Rights Reserved
by Erik Muenker D.C. |  Exclusive CBDbusinessBlog.com

 Erik Muenker Editor CBD Business Blog     Twitter  |  Google+  |  Linkedin

Vermont – May 2, 2017
Vermont Lawmakers Approve Expansion of Medical Marijuana.

The Associated Press reports that Vermont lawmakers are expanding access to medical marijuana in the state. Legislators have approved a bill that would add additional ailments to the list of qualifying conditions AND triple the number of dispensaries in the state.

Continue reading “Vermont Set To Expand Medical Marijuana”

2017 Federal Spending Bill Extends Key Marijuana Protections

Copyright © Erik Muenker 2017 All Rights Reserved
by Erik Muenker D.C. |  Exclusive CBDbusinessBlog.com
 Erik Muenker Editor CBD Business Blog     Twitter  |  Google+  |  Linkedin

WASHINGTON – May 1, 2017
Marijuana advocates have reason to celebrate.

The recent Omnibus spending bill passed by the 115th GOP led Congress, maintains a key provision that has been protecting legal medical marijuana operations from federal prosecution since 2014.

Originally introduced in 2003, the Rohrabacher-Farr amendment did not become law until inclusion in the 2014 Omnibus Spending Bill. The amendment, known now as Section 542, is hidden away on page 223 of a 2000+ page spending bill. The section reads as follows: Continue reading “2017 Federal Spending Bill Extends Key Marijuana Protections”

Federal Legalization of Medical Marijuana Could Save Government $3.8 Billion

Copyright © Erik Muenker 2017 All Rights Reserve
by Erik Muenker D.C. |  Exclusive CBDbusinessBlog.com

In a new STUDY published by Health Affairs (April, 2017), the authors Ashley Bradford and W. David Bradford propose that the nation could save between $1 billion – $3.8 billion annuallyif medical marijuana was federally legal and available in every state.

How is this possible?

Continue reading “Federal Legalization of Medical Marijuana Could Save Government $3.8 Billion”

Americans support for Legal Marijuana Climbs to 60%!

Copyright © 2017 All Rights Reserved
by Erik Muenker D.C. |  Exclusive CBDbusinessBlog.com

HAPPY 420 | Great news to celebrate!

WASHINGTON, D.C. — According to the latest Gallup Poll, the support for legal marijuana stands at an all-time high of 60%!

Gallup Q: “Do you think the use of marijuana should be made legal, or not?

A: 60% said YES, legalize

      Americans approve of legal marijuana!
          * Gallup Poll Oct. 2016

Continue reading “Americans support for Legal Marijuana Climbs to 60%!”

Wisconsin Legislature Unanimously approves Marijuana CBD Oil

Copyright © 2017 All Rights Reserved
by Erik Muenker D.C. |  Exclusive CBDbusinessBlog.com

 

Updated March 28th, 2017

Wisconsin State Capitol
Wisconsin State Capitol

Madison, WI – The Wisconsin state Assembly voted 98-0 last week, to legalize possession of CBD oil! CBD oil is a marijuana extract and is used to treat seizures, reduce pain and inflammation and may even be effective as a neuro-protectant. It won’t get you high, but many people swear by its benefits.

With the state Senate having overwhelmingly approved the bill, it now moves on to the governor’s desk for his signature. Gov. Scott Walker is expected to sign the legislation into law.

Unfortunately (for many), the Wisconsin bill does not go far enough. For one thing, the legislation does not allow for the production or sale of CBD oil in Wisconsin. Parents are expected to obtain CBD oil from outside the state. Then bring it back into Wisconsin, in violation of federal law. Seems a little short-sighted, doesn’t it?


Updated March 28th, 2017 

NORML-Madison-WisconsinNORML – Madison reports that Wisconsin City has removed fines for marijuana possession and consumption. 

Under a new ordinance passed this week in March, adults 21+ will no longer be subject to fine for possessing marijuana (public or private).  Using marijuana in private is also exempt from any fines. However, public use is still prohibited and subject to a $200 fine.


Continue reading “Wisconsin Legislature Unanimously approves Marijuana CBD Oil”

Spotlight: Marijuana company Canopy Growth now in S&P/TSX Index

Copyright © 2017 All Rights Reserved
by Erik Muenker D.C. |  Exclusive CBDbusinessBlog.com

 

Canopy_Growth_Corporation_logo.svg

SMITH FALLS, Ontario – Another milestone for the cannabis industry was reached today

Canopy Growth [TSX:WEED], Canada’s largest and arguably most successful marijuana company – has been added to the S&P/TSX Composite Index. The index represents nearly 70% of the total market capitalization on the Toronto Stock Exchange and is considered a key benchmark for the Canadian equity market.

With the addition of Canopy Growth to the index, more and more investors will now be buying and holding weed.

Canopy Growth has a market capitalization of $780.6 million and a year-to-date stock price change of +192%. Canopy Growth is definitely a cannabis company to watch in 2017.


Update – March 27th, 2017
Legal Marijuana in Canada by 2018
Legal Marijuana in Canada by 2018

According to the CBC, PM Tradeau will announce legislation on April 10th – to legalize marijuana for recreational use in Canada by July 1, 2018!

Shares of Canopy Growth Corp. jumped 11% in trading on the news.

Continue reading “Spotlight: Marijuana company Canopy Growth now in S&P/TSX Index”

Celebrating Powerful Women in Weed on International Women’s Day

Copyright © 2017 All Rights Reserved
by Erik Muenker D.C. |  Exclusive CBDbusinessBlog.com

The CBD Business Blog

would like to celebrate

International Women’s Day

by celebrating

Powerful Women In Weed

Women in Weed Lg
Powerful Women in Weed

Is GOP led 115th Congress Shifting Views on Marijuana with new Legislation?

Copyright © 2017 All Rights Reserved
by Erik Muenker D.C. |  Exclusive CBDbusinessBlog.com

Breaking News: Multiple Marijuana Legislative Bills could Signal Shift IN GOP

At least two bills have been introduced by Republican lawmakers in the past 6 weeks, that would end federal marijuana prohibition.

I’m Just a Bill – H.R. 715

On January 27th, 2017 – House Republican Rep. Griffith Morgan from Virginia introduced H.R. 715 to the 115th Congress. Legislation that would reschedule marijuana from a Schedule 1 Controlled Substance, AND exclude cannabidiol (CBD) from the definition of marijuana

Read more by clicking the image below.

HR715 De-schedules CBD

 

I’m Just a Second Marijuana Bill!

On February 27th, 2017 – House Republican Rep. Thomas Garrett of Virginia introduced legislation entitled, Ending Federal Marijuana Prohibition Act of 2017.

Rep. Garrett’s legislation, if it becomes law, would end federal prohibition by removing marijuana from the Controlled Substances Act. This would in effect, leave marijuana legality/policy up to the states.

Rep. Garrett has been a vocal Trump Supporter and the timing of his bill is worth noting. AG Sessions himself suggested during his confirmation hearings – that if congress didn’t like his approach to marijuana law enforcement, they should change the laws accordingly.

Perhaps the Republicans are attempting to do just that?! First with a stick, then with a carrot?

Garrett’s office released a press release to coincide with the legislation’s introduction:

WASHINGTON, D.C. – Today 5th District Congressman Tom Garrett introduced legislation aimed at federally decriminalizing marijuana.

The short title for this legislation is cited as the “Ending Federal Marijuana Prohibition Act of 2017.” If passed, this bill would take marijuana off the federal controlled substances list – joining other industries such as alcohol and tobacco.

Garrett went on to say,

“this step allows states to determine appropriate medicinal use and allows for industrial hemp growth, something that will provide a major economic boost to agricultural development in Southside Virginia. In the coming weeks, I anticipate introducing legislation aimed at growing the hemp industry in Virginia, something that is long overdue.”

Senators on Marijuana in 2017

Take a listen to Senator Schatz as he blasts AG Sessions on the Senate floor, February 8th, 2017 – over his comments disparaging marijuana.

According to the Associated Press (article), Senators from eight states with legal recreational marijuana (Washington, Colorado, Nevada, California, Oregon, Massachusetts, Maine, Alaska), sent a letter to Attorney General Jeff Sessions on March 2nd, 2017 – asking him to uphold the Department of Justice’s existing enforcement policy toward marijuana.

Among those who signed this letter where Senators Elizabeth Warren and Edward Markey.

United States Marijuana Map Twitter
2017 Election  Marijuana Map

Related: Election 2016 – Marijuana Legalization Spreads Across the U.S.

Trump on Marijuana

Republican Presidential Candidate Donald speaks in front of a crowd in Reno, Nevada on October 29th, 2015.

Listen to Trump’s answer, when asked how he would approach medical and recreational marijuana.

Continue reading “Is GOP led 115th Congress Shifting Views on Marijuana with new Legislation?”

Breaking News: House Republican Bill Would Reschedule Marijuana and De-Schedule CBD

 

Copyright © 2017 All Rights Reserved
by Erik Muenker D.C. |  Exclusive CBDbusinessBlog.com

115th Congress 1st SessionHouse Republican Rep. Griffith Morgan from Virginia, has introduced a bill to the 115th Congress that would reschedule marijuana from a Schedule 1 Controlled Substance, AND exclude cannabidiol (CBD) from the definition of marijuana.

Part I – The Big News | Reschedule Marijuana!

Marijuana Bill Becomes Law
Introduced in the House of Representatives on January 27, 2017, H.R. 715 would reschedule marijuana under section 202 of the Controlled Substance Act (21 U.S.C. 812) to a schedule under section 202 other than the dreaded schedule I.

 

Schedule I is reserved for substances that have a high potential for abuse, have no currently accepted medical use, and demonstrate a lack of acceptable safety when used under medical supervision.

No accepted medical use?

Not so fast! Clearly, marijuana does not belong under Schedule I. Marijuana has demonstrated health benefits. CBD oil, from marijuana and hemp, is used by many people to treat joint inflammation and the pain and stiffness associated with arthritis. And CBD is not psychoactive, meaning it won’t get you high.

Science is just now beginning to explore the potential health benefits of cannabis. Recent clinical research suggests applications in the treatment of anxiety and schizophrenia, and even cancer. The THCV and terpenes in marijuana and hemp may even help you maintain healthy blood sugar levels and possibly even help you avoid serious health problems such as diabetes

This bill, if passed, would be truly historic. It would completely alter the landscape for the cannabis industry nationally and perhaps even globally. Although rescheduling alone would likely not immediately end Federal prohibition, it would drive a huge crack in the wall of ignorance surrounding medical and recreational marijuana.

Part II – Equally Great News | CBD Excluded from CSA!

H.R. 715 would also remove cannabidiol (CBD), famous for its efficacy in treating intractable childhood epilepsy (e.g. Dravet Syndrome, Lennox-Gastaut Syndrome), from governance under the Controlled Substance Act!

Learn why cannabidiol (CBD) and how the industry is expecting 700% growth.

An End to Federal Prohibition?

H.R. 715, by itself, would not prevent the FDA from restricting and regulating marijuana, but it would remove the DEA from the conversation.

Passage would also likely permit banks and other financial bodies to engage with state-compliant marijuana companies. This would bring much needed capital and financial security to an industry producing billions of dollars outside of mainstream financial institutions and poised to be crowned the #1 most valuable legal cash crop in the U.S.

Update: House Republicans have introduced a second marijuana Bill that would end Federal prohibition Click for info

2-GOP Bills Feature-new-03





I’m Just a Bill – A Marijuana Bill

Continue reading “Breaking News: House Republican Bill Would Reschedule Marijuana and De-Schedule CBD”

Trump Pick For FDA Could Help Marijuana Industry | But At What Cost?

Copyright © 2017 All Rights Reserved
by Erik Muenker D.C. |  Exclusive CBDbusinessBlog.com
Jim O’Neill Could Bring Disruption and Marijuana to the FDA
Jim O'Neill - FDA-candidate
Jim O’Neill Courtesy Mithri Capital

According to Bloomberg News and TheHill, President Donald Trump is strongly considering Jim O’Neill, an outspoken marijuana supporter and libertarian, to be the next head of the FDA. Jim O’Neill has been a staunch critic of the FDA for years and if appointed to lead the agency, he is likely to usher in dramatic changes that could shake the agency to its core. And maybe, just maybe, that’s not such a bad thing.

Peter Thiel
Peter Thiel – Trump transition team

Jim O’Neill is reportedly a close business associate of key Trump transition team member Peter Thiel – a tech financier worth more than $2 Billion. Theil was named #246 on the Forbes 400 List of Richest People in America in 2016. Theil spokesman Jeremiah Hall was quoted recently in an email reported by Bloomberg Politics, “Jim O’Neill has extensive experience in government and in Silicon Valley. He is a strong candidate for any of several key positions.”

Mr. O’Neill is currently the Managing Director of Mithril Capital Management LLC,

mithril

a global investment firm cofounded by Peter Thiel. Previous to Mithril Capital, Mr. O’Neill spent just under six years working in various roles for the Department of Health and Human Services during the George W. Bush Administration, from 2002 – 2008. O’Neill first served as the Director of the Speech and Editorial Division, then as Associate Deputy Secretary and ultimately as the Principal Associate Deputy Secretary contributing to policy and regulatory matters affecting the FDA.

In addition to working for the Dept. of HHS, O’Neill also served on the Board of Directors (and was a founding member) for the Coalition for Cannabis Policy Reform. CCPR is a nonpartisan organization which opposes prohibition and supports reasonable marijuana regulation. O’Neill is likely to bring big changes to the FDA, easing research and perhaps access to cannabis based pharmaceuticals and nutraceuticals.

Continue reading “Trump Pick For FDA Could Help Marijuana Industry | But At What Cost?”

Cannabidiol and Marijuana News and Views | @CBDbusinessBlog on Twitter

Follow-Us-On-Twitter-2017
Follow Us On Twitter

Interested in the Legal Marijuana Industry?

Follow the CBD Business Blog on Twitter and stay up-to-date on all of the latest marijuana industry news, with a focus on cannabidiol (CBD) – the amazing nutraceutical found in cannabis.


About the Author
Erik Muenker D.C. – Portland, OR
Founder and Editor of CBD Business Blog |  Twitter: @CBDbusinessBlog

CBD-BB Logo and URLDr. Erik Muenker D.C. is the Publisher and Editor of the CBD Business Blog, an online blog and journal – your source for exclusive business, scientific, health and political news impacting the recreational and medical marijuana industries.

Our focus is on cannabidiol (CBD), a non-addictivenon-psychotropic and medically powerful cannabinoid found in marijuana and hemp.                Disclaimer